1. Social Determinants of Poor Management of Type 2 Diabetes Among the Insured

   • Minal R. Patel

   Diabetes Epidemiology (S Albrecht, Section Editors) 05 November 2020 Article: 67

2. Novel Targets in Glucose Homeostasis and Obesity—Lesson from Rare Mutations

   • Bing Feng
   • Pingwen Xu
   • Yanlin He

   Obesity (KM Gadde and P Singh, Section Editors) 31 October 2020 Article: 66

   

3. The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction

   • Xiaowen Wang
   • Subodh Verma
   • Deepak L. Bhatt

   Macrovascular Complications in Diabetes (VR Aroda and L-S Chang, Section Editors) Open access 23 October 2020 Article: 65

   

4. Tissue-Specific Fructose Metabolism in Obesity and Diabetes

   • Robert N. Helsley
   • Francois Moreau
   • Samir Softic

   Pathogenesis of Type 2 Diabetes and Insulin Resistance (M-E Patti, Section Editor) 15 October 2020 Article: 64

   

5. What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?

   • Muhammad Shahzeb Khan
   • Muthiah Vaduganathan

   Macrovascular Complications in Diabetes (VR Aroda and L-S Chang, Section Editors) 11 October 2020 Article: 63

6. Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent

   • M. Larissa Avilés-Santa
   • Alberto Monroig-Rivera
   • Nangel M. Lindberg

   Diabetes Epidemiology (S Albrecht, Section Editors) 10 October 2020 Article: 62

   

7. Do Women with Diabetes Need More Intensive Action for Cardiovascular Reduction than Men with Diabetes?

   • Jürgen Harreiter
   • Helena Fadl
   • David Simmons

   Macrovascular Complications in Diabetes (VR Aroda and L-S Chang, Section Editors) Open access 09 October 2020 Article: 61

   

8. Integrating Genetics and the Plasma Proteome to Predict the Risk of Type 2 Diabetes

   • Julia Carrasco Zanini
   • Maik Pietzner
   • Claudia Langenberg

   Genetics (AP Morris, Section Editor) Open access 08 October 2020 Article: 60

   

9. Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease

   • Jeffrey Budd
   • Kenneth Cusi

   Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors) 05 October 2020 Article: 59

   

10. Thyroid Hormone Signalling Alteration in Diabetic Nephropathy and Cardiomyopathy: a “Switch” to the Foetal Gene Programme

    • Polyxeni Mantzouratou
    • Angelo Michele Lavecchia
    • Christodoulos Xinaris

    Microvascular Complications—Nephropathy (B Roshanravan, Section Editor) 28 September 2020 Article: 58

    

11. A Review of the Current Evidence: Impact of Metabolic Surgery on Diabetes Outcomes and Obesity-Associated Macrovascular Complications

    • Karim G. Kheniser
    • Ali Aminian
    • Sangeeta R. Kashyap

    Macrovascular Complications in Diabetes (VR Aroda and L-S Chang, Section Editors) 28 September 2020 Article: 57

12. The Role of Socioeconomic Status in Latino Health Disparities Among Youth with Type 1 Diabetes: a Systematic Review

    • Daniel Mello
    • Deborah Wiebe

    Psychosocial Aspects (SS Jaser, Section Editor) 25 September 2020 Article: 56